Skip to main content
KBS_Icon_questionmark link-ico


Carsten Flohr studied at Cambridge and Oxford Universities and then trained in both paediatrics and dermatology. He was the first UK National Institute for Health Research (NIHR) Clinician Scientist in Dermatology (2009-2014) and also held a Career Development Fellowship from the NIHR (2014-2020).

Carsten Flohr is Chair in Dermatology and Population Health Sciences at King’s College London and Honorary Consultant in Dermatology as well as Research & Development Lead at St John’s Institute of Dermatology, Guy’s & St Thomas’ NHS Foundation Trust, London, UK.

Professor Flohr has a particular interest in population-based dermatology research and clinical trials with a focus on atopic eczema. For instance, he is Chief Investigator of the NIHR-funded TREatment of severe eczema in children Trial (TREAT), which compares ciclosporine with methotrexate in children with recalcitrant atopic eczema. He is also Chief Investigator of the UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR) and the EU Horizon 2020 Joint Program Initiative-funded Trans-Foods and the Mind & Skin consortia. The Flohr Group also investigates host-skin and gut microbiome interactions in inflammatory skin disease. In addition, Professor Flohr leads the International League of Dermatological Societies (ILDS) Global Atopic Dermatitis Atlas project.

Professor Flohr is a Founding Director of the International Eczema Council and Past President of the British Society of Paediatric and Adolescent Dermatology. He is also Founding Editor of the Evidence-Based Dermatology Section of the British Journal of Dermatology and the Clinical Trials Editor of the F1000 Atopic Dermatitis Section.